Skip to main content
Figure 3 | Breast Cancer Research

Figure 3

From: RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells

Figure 3

Analysis of drug combinations on growth of breast cancer cells grown in 3D cultures. A. Cells were seeded on Matrigel in eight-well chamber slides as described in Materials and Methods. 3D cultures formed after two days and were treated every two to three days with single agents, vehicle (control), 1 nM paclitaxel (tax), 500 nM LY2109761 (LY), 10 μM CCT007093 (CCT), 25 nM mithramycin (mith) (upper panels) or a combination of drugs (lower panels). After 10 to 14 days, mammospheres were visualized using phase-contrast microscopy. Bar scale, 50 μm. B. To count cell numbers, the Matrigel was dissolved, mammospheres were collected, trypsinized and single cells were counted by trypan blue exclusion assay using a hemocytometer. The percent cell number relative to control was plotted for each drug or combination for the two cell lines. Error bars represent standard deviation from replicates from three independent experiments.

Back to article page